Kineta's research on antiviral drugs attracts $2.8M NIH grant

08/12/2011 | American City Business Journals

The NIH's National Institute of Allergy and Infectious Disease awarded a $2.8 million grant to Kineta to develop drugs against RNA viruses, including hepatitis and flu. "Our goal is to find novel drugs that can treat infections for the long term," said Kristen Bedard, the firm's principal scientist in virology.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Sr. Compliance Director Ethics and Compliance
Medtronic
Fridley, MN
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC